A peptide dosage chart, one peptide at a time: its dose range, how often it’s taken, a typical run and the units on your syringe. All 69 peptides in the PepVault library.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
Two weekly drugs in one regimen: cagrilintide, a long-acting version of the fullness hormone amylin, and semaglutide, the GLP-1 drug in Wegovy and Ozempic. Amylin and GLP-1 curb appetite through partly different routes, so together they go further than either alone; Novo Nordisk filed it for FDA approval in December 2025. Commonly reported: strong appetite suppression and early fullness, with nausea, vomiting or constipation through the dose steps. In its main trial people lost about 20% of body weight on average at 68 weeks, more than on semaglutide alone; it is not approved yet.
Sold ready to use, never as a powder you mix, so there’s no mix to work out.
CagriSema in the peptide libraryThe Dose Guide: every peptide
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.
PepVault logs every dose, keeps count of the doses left in your vials, and reminds you on your schedule.
Get PepVault on the App Store7 days free on the yearly plan for new subscribers.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.